April 2, 2001 -- Eric Taylor suffered from back pain for almost 30 years. He tried physical therapy, pain relievers, anti-inflammatory medicines, and surgery, but nothing worked. His doctor told him he could have steel rods placed in his spine or put up with the pain for the rest of his life.
Taylor sought an alternative. A friend told him about a new procedure called vertebral axial decompression (VAX-D) that might relieve pain without surgery. Taylor thought, why not?
By Sarah Mahoney
There's an inevitable rhythm to January 1 at my house. I take down the tree, vacuum up pine needles, and start making my New Year's resolutions. The list usually looks like this: Lose weight. Swear off TV and saturated fat. Eat salads. Call Dad more. Write that novel. Floss. By midday I'm worn out, intermittently dozing in front of a football game and swiping my husband's million-calorie nachos.
It's not that I totally lack discipline. It's just that I don't sufficiently appreciate...
"As long as it was nonsurgical and noninvasive, I was open to it," says Taylor, a 54-year-old attorney in St. Louis. "I was ready."
Nearly 70% of all people will suffer from low-back pain at some point in their lives, according to the CDC. It is the most common work-related injury, the Occupational Safety and Health Administration (OSHA) reports. There is little, however, that can be done. Bed rest is the most prescribed remedy, followed by exercise, muscle relaxants, pain medication, physical therapy, chiropractic intervention, and surgery. These and other methods often fail to provide long-term relief. But researchers say there is new hope: The VAX-D therapeutic table.
Approved by the FDA in 1996, the device was designed by Allan E. Dyer, MD, PhD, a former Canadian deputy health minister who helped develop the heart defibrillator. Treatment using the table is said to relieve lower back pain by applying tension to the spinal column to decompress the intervertebral discs.
A study published in April 1998 in The Journal of Neurological Research found that VAX-D is effective in relieving pain in 71% of cases. The majority of the 778 patients -- cases reviewed from 22 centers across the country -- reported a reduction in pain to a level of 0 or 1 on a 0 to 5 scale (with 5 being the highest level of pain). About 1% of patients reported an increase in pain, while 7% experienced no change. About 4% of the patients had had previous lumbar disc surgery. The researchers suggest that postsurgical patients who still have persistent pain should try VAX-D before considering further surgery.